Pathoquest
French tech company | Builders Republic
About
Contract research organization (CRO) providing GMP-grade biosafety testing and biopharmaceutical characterization using next-generation sequencing — offering viral safety testing, cell line characterization, integration site analysis, and raw material screening for drug developers across mAbs, viral vectors, cell therapies, vaccines, and RNA therapeutics via the iDTECT platform.
Key facts
- Status
- Rachetée
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series B
- Founded
- 2010
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 15 M€ raised since 2020
Funding rounds
- Series B — 2021
Investors
- Aurinvest
- Eurazeo
- Kurma Partners
- SHS Capital
- Turenne Capital
- Verve
Notes
Rachetée par Charles River Laboratories : option sur les 79% restants exercée le 12/01/2026 (~60 M$), closing attendu au Q1 2026.